Ronak Shah
Family Medicine · Brookline, MANPI 1184079154
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,883 of the $7,369 with a category attached, or 66.3%. 6 manufacturers reported payments, led by Roche Diagnostics Corporation at 50.8% of the total. Reporting peaked in 2024 at $6,824 and has fallen 98.4% since, to $107 in 2025. Among family medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 7 payments — averaging $1052.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche Diagnostics Corporation$4K
- Pfizer$3K
- Visby Medical, Inc.$238
- Roche Molecular Systems, Inc.$200
- Talis Clinical LLC$107
- Abbott$81
What the payments were for
- Consulting fees$4,88366%
- Speaking & faculty fees$2,06028%
- Food & beverage$4266%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche Diagnostics Corporation | 2 | $3,743 |
| Pfizer | 1 | $3,000 |
| Visby Medical, Inc. | 1 | $238 |
| Roche Molecular Systems, Inc. | 1 | $200 |
| Talis Clinical LLC | 1 | $107 |
| Abbott | 1 | $81 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,369 in reported general payments places this provider in the 95th percentile of 1,049 family medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $82 |
| Azithromycin | 14 | $44 |
| Prednisone | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Brookline
- Larry CulpepperBoston$109K
- Jennifer WeylerWorcester$105K
- Megan McCoyFramingham$75K
- Kristina GraceyWorcester$73K
- Suzanne MitchellBoston$69K
- John GrievesonLowell$24K
- James SalemisRoslindale$24K
- David FarzanLawrence$23K
- Julie JohnstonLawrence$21K
- Sanjeev SharmaFramingham$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.